110
Archived articleThis is an archived article from 2024 - please note that any content within the article may be out of date.

Week Ahead: Housing focus | Asset managers | US consumers | Quality industrials

Good morning and welcome to the Week Ahead, your weekly destination for discussion and analysis of the largest stocks in the UK and overseas.

This week is another busy period for FTSE 100 earnings. An interesting mix of companies are due to report, including some cyclical names that might provide some clues on the health of the UK economy.

With the UK now technically in recession, UK economic data on mortgage approvals, consumer credit and manufacturing PMIs may provide some insight into consumer confidence and the health of the industrial sector.

Housing is likely to attract particular interest, with results due from Taylor Wimpey (LON:TW.) , Rightmove (LON:RMV) and kitchen specialist Howden Joinery (LON:HWDN). The latest Nationwide House Price Index is also due to be published on Friday. This comes on top of this morning’s announcement from the Competition and Markets Authority (CMA) citing concerns about planning systems and estate management charges. The CMA has also said it is opening a further investigation into eight of the UK’s listed housebuilders who it suspects of sharing information. All of the housebuilders named in the announcement are trading down about 2% this morning.

Across the pond, a raft of US economic data is due that may provide reassurance (or not) about the health of the world’s largest economy in its election year.

Former FTSE 100 member CRH is also due to report its results on Thursday. This will be the building materials group’s first set of numbers since moving its primary listing to New York. That move has coincided with a significant re-rating of CRH shares, so it will be interesting to see if CEO Albert Manifold remains positive on the prospects for the year ahead.

Coming up this week…

Day

Big UK earnings

US company reporting

Economic announcements

Monday - 26 Feb

Bunzl full-year results

Domino’s Pizza Inc final results

Zoom Video Communications final results

US new Home Sales report

Tuesday - 27 Feb

Smith & Nephew final results

Abrdn final results

Croda International final results

Unite Group final results

eBay final results

Lowe’s Companies final results

Constellation Energy final results

Lemonade final results

US Consumer Confidence index

US Durable Goods Orders

Wednesday - 28 Feb

Reckitt final results

Taylor Wimpey final results

St James’s Place final results

Primary Health Properties final results

Just Eat Takeaway interim results

HP Q1 results

Salesforce final results

AMC Entertainment final results

Thursday - 29 Feb

Haleon final results

CRH final results

Spectris final results

Howden Joinery final results

International Airlines Group final results

London Stock Exchange final results

Schroders final results

Drax final results

Weir Group final results

Anheuser-Busch Inbev final results

Birkenstock Holding Q1 results

Autodesk final results

HP Enterprise Q1 results

UK mortgage approvals

UK net consumer credit

US jobless claims report

Friday - 1 Mar

Rightmove final results

Pearson final results

Tritax Big Box REIT final results

IMI final results

UK Nationwide House Price Index

UK Markit Manufacturing PMI

US ISM Manufacturing PMI

EU Inflation (flash)

China NBS Manufacturing PMI


FTSE 350 results: good, bad and ugly?

Are asset managers at an inflection point?

Last week was a busy period for UK bank earnings. This week it’s the turn of some of the larger asset managers, with Schroders (LON:SDR), St James's Place (LON:STJ), and Abrdn (LON:ABDN) all due to report. Remarkably, shares in all three companies are currently trading at 10-year lows.

Shares in St James’s Place have completely reversed the 100% gain achieved from 2014-2021 and are currently trading 20% below 2014 levels. Investors will be looking for reassurance that the company’s new fee structure will support the 8% dividend yield and keep the FCA happy.

Abrdn shares currently trade at around 20% below tangible book value and offer a tempting 8.9% dividend yield. However, this payout looks stretched to me and my feeling is that it has only been sustained this far by cash generated from divestments.

The group’s assets under management have now fallen by more than 25% since Aberdeen Asset Management combined with Standard Life in 2017.

The highlights (lowlights?) of Abrdn’s 2023 results were trailed to the market through an update in January, so we already know that AUM continued to fall in 2023, with further outflows during the second half of the year.

Abrdn’s January update also revealed plans for a further £150m of cost savings and a round of job cuts. Not necessarily a working environment that’s conducive to improved performance.

While most asset managers look unloved at the moment, I suspect Abrdn will find it harder than most to win back investor confidence. Investors’ best hope in the short term might be a takeover offer from a larger rival.

My pick of the bunch is Schroders, which is a larger and classier outfit with more stable performance and robust financials. The family-controlled group’s larger scale and considered long-term strategy have supported an unbroken 35-year dividend record.

While Schroders’ yield is more modest at 5.5%, I think there’s little doubt about its sustainability.

Look out for: changes to fee margins and any evidence that net outflows may be slowing or even reversing.

Quality industrials: is the outlook stabilising?

Problems such as destocking and slower-moving order pipelines dogged a number of good quality FTSE 350 industrial firms last year. Perhaps the highest-profile casualty was chemicals group Croda International (LON:CRDA), which disappointed the market with multiple profit warnings.

Despite negative sentiment, I feel this remains a market-leading, high-quality business. However, while Croda shares have de-rated substantially, they continue to trade on 30 times forecast earnings.

Some evidence of a more stable outlook may be needed to prevent further erosion of the share price – note that Stockopedia’s algorithms continue to classify this business as a Falling Star, ahead of Croda’s 2023 numbers.

Elsewhere in the industrial and technology sectors, precision measurement group Spectris (LON:SXS) and distribution specialist Bunzl (LON:BNZL) both reported more resilient trading last year. Both also delivered robust share price performances. Investors will be watching keenly for updated 2024 guidance.

Look out for: any disappointment from last year’s high flyers could be quickly punished. Watch for signs of improving demand and margin recovery.

US earnings: can Bud regain its fizz?

Changing drinking fashions, rising costs and a misfiring marketing campaign for Bud Light have created headwinds for Budweiser owner Anheuser-Busch Inbev SA (NYQ:BUD) over the last year. Net debt of nearly $74bn is likely to be an added pressure, given higher interest rates.

Consensus forecasts for the beer group have edged lower over the last year but continue to suggest a partial recovery in earnings for 2024. Inflation has now eased and some analysts are suggesting that beer companies could benefit from a downturn in more expensive spirit sales - Diageo (LON:DGE) recently reported a drop in North American volumes for 2023.

Elsewhere in the US, results from consumer firms including eBay (NSQ:EBAY), Domino's Pizza (NYQ:DPZ), home improvement retailer Lowe's Companies (NYQ:LOW) and loss-making cinema chain AMC Entertainment Holdings (NYQ:AMC) may provide more insight into the current health and habits of US consumers.

Finally, Q1 earnings from Birkenstock Holding (NYQ:BIRK) will provide a fresh update on the performance of this much-loved footwear brand – Birkenstock shares have risen by over 40% since its October IPO.

Look out for: changing consumer spending patterns, post-IPO progress and debt woes.

Disclosure: At the time of publication, Roland owned shares in CRH.

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

16 comments


Avatar for Mark Carter

Fri.

IMI Results out and seemed to have disappointed the markets a little.

Sigh, IMI is a company that I was aware of yonks ago, and reckoned was a good company. To my surprise the shares have barely budged over 10 years. I had figured they'd have done well.

Still, it has a Q score of 93, suggesting good quality. Its returns on capital are good, and its debt level OK. Its fwd PE ratio is around 14, which is very reasonable. I see that they've reduced the dividends as of 2020. Their operating and free cashflows have gone up though.

They've been increasing their dividend cover. Actually, that's something I've noticed with quite a few companies lately. Hopefully they see reinvestment opportunities, which would be great.

IMI strikes me as a good quality company at a reasonable valuation. I don't own it, but it looks pretty good to me. There are so many opportunities out there at the moment, it's hard to know what to choose. There are more exciting things than IMI out there, but it looks like a solid pick to me.

I'm also generally quite impressed with the quality of companies on offer in the UK market. I'm usually down on large-caps in general, viewing them as over-the-hill dinosaurs. But having looked through more of them, I find myself pleased with the fact that I think many of the large-caps are actually quite good.

Anyway, I just wanted to share my tuppence on IMI. Have  a good weekend everyone.

3
Avatar for Mark Carter

Several companies that I have shares in reported today (Thu). Given some awful market reactions to companies reporting results yesterday (e.g. RKT), I was very much braced for impact.

HLN 338p+8% in early trading. I bought these shortly after they were spun out, and topped up at a later date. HLN is in the healthcare sector, selling such things as Sensodyne, Panadol and Advil.

HLN is perhaps not something to get too excited about, you're not going to get a 10-bagger within 10 years on this. Demerging from GSK certainly seems to have done wonders for the company. It expects organic revenue to rise 4-6%.

Net debt is expected to be £8514m (2022: £9834m). It's good to see that debt go down.

Net cash from operating activities is expected to be £2100m (2022:2063m).

So, everything seems to be going in the right direction. 

1
Avatar for Mark Carter

DLG 189p+16% Possible offer.

I had contemplated this as a buy earlier this year. Shares were trading at near a 20-year low, good divvie, great customer service, and have you seen how much my car insurance went up last year?

Buy what you know and all that, except that I didn't. Oh well, better luck next time.

1
Avatar for Keelan Cooper

Hi Mark, 

Another week, another takeover offer!

It looks like plenty of companies are noticing the valuation discounts apparent in UK equities at the moment.

You may have missed the initial jump with Direct Line Insurance (LON:DLG), but there could always be further counteroffers if the shares are still underpriced. 

Wincanton (LON:WIN) just received its 3rd bid this week, and the price has even surpassed the latest offer in the expectation of another bid coming in!

Will be taking a closer look at UK takeovers in the coming weeks. Stay tuned. 

Hope you have a great weekend. 

Best,
Keelan 

4
Avatar for Mark Carter

I was listening to a podcast where Paul Scott was interviewed. He said that he was talking to someone who said that US private equity had talked to "every" UK company about a deal.

I like a cheap market even more than the next guy, but I really don't like see good quality businesses being taken over, especially at these valuations.

The market right now reminds me a little of the 2022/3 (approx) period, when we came off the 2000 tech bubble. Smaller cap value was bargain basement. I had bought a few shares based on low valuations and good balance sheets. I was surprised that a large percentage of the shares I owned were taken over. 

One of them was Amstrad, as it happens. A third of the value of the company was in cash IIRC, and I had only held it for a few months before the takeover was announced.

3
Avatar for Mark Carter

SJP 423p-32% Finals. Shares hits an 11-year low. Ouch. It has put aside a £426m client refund provision. That is less than the fall in mkt cap today. Loss after tax was £9.9m compared to profit of £407m last year. Potential contrarian play perhaps?

I have a little story. Aways back, a work colleague had an appointment at the offices of SJP (I'm pretty sure it was) to meet and increase his pension. I happened to pass the place one day and noticed that their car park was full of lovely motors.  Real expensive stuff. I thought to myself at the time that it was a right good racket to be in.  Someone's got to be paying for all that, I figured. Skip forward to the present, and here we are.

RKT 5350p-8% Q4 disappoints. That's a big drop for a company in consumer defensives. Hargreaves Lansdown says "Cost cuts can only support margin growth for so long ... performance across pretty much all business areas was weaker than expected.

RKT has a 5-yr ROCE avg of 5.1%, which is pretty weak for a company that sells branded goods. PZC is a little higher at 8.6%, but still lacklustre. I once had a shareholding in PZC, and it performed terribly, as you can imagine.

ULVR has the kind of ROCE I was expected, at 20.8%. Its shares have only moved sideways over the last 5 years. I own shares in ULVR, for which I am currently underwater. Analysts have been consistently lowering estimates over the last year, which isn't so good.

You'd think that these branded goods would have a lot of pricing power, but they've been struggling. 

3
Avatar for Thomas Whitehead

St James's Place (LON:STJ) taking an absolute battering today - down over 30%. It turns out ripping people off is not a good business model any more.

11
Avatar for intuitive6191

Monthly newsletter from Lynn Alden. some interesting comment/charts on the US.

https://www.lynalden.com/febru...

2
Avatar for Mark Carter

ABDN up nearly 5% in early trading, slightly beating profit estimates (£249m vs £242m). Analyst had been upgrading estimates throughout the year. PBV of 0.55, which strikes me as hellishly cheap.

Share price is near a 20-year low.  Directors had bought approx £420k of shares last year.

This strikes me as a contrarian value trade. I do not hold. 169p

4
Avatar for Mark Carter

Nice summary.

BNZL down 4.7% today. Forecast PE is 17.9, so maybe market doesn't like to see any signs of weakness. Margins have slipped a little, but revenues are expected to be up a little. It's a good quality company. I hold. 

4
Avatar for donald pond

Celsius Holdings (NAQ:CELH) earnings on Thursday are also worth keeping an eye on. They make "functional energy drinks" for pre and post workouts but have very slick packaging and are growing very fast. Worth remembering that Monster Beverage (NSQ:MNST) were I think the best performing share in the US for their 10 year period of high growth. CELH unlikely to match that, but it is very different to Monster, with gender neutral packaging, a very clean look, and sales growing at a very fast rate. 
Hedgeye reported that US stores in general are reducing the amount of space given to beer and increasing the amount given to soft and sports drinks, and CELH are a prime beneficiary. That may be relevant to Anheuser-Busch Inbev SA (NYQ:BUD) . 

I'd note that the same dynamic appears to be happening in sports shops, where the shelf space given to Nike (NYQ:NKE) is being reduced in favour of upstart brands like On Holding AG (NYQ:ONON) and Brooks, which is owned by Berkshire Hathaway (NYQ:BRK.A) . It could be that we are at a point where the big global brands start losing traction as younger generations never perceive them as cool. When I was growing up, there were no challenger brands. Its an interesting change in dynamic which I don't think people have noticed.

12
Avatar for StrawberryDreams

Nike (NYQ:NKE) had a bit of a clanger (profit warning) farily recently and seem to be returning to some of the stores which they were reducing supply to, including Foot Locker (NYQ:FL, which they were leaving in favour of the direct to consumer model.Perhaps they're finding that brands like Foot Locker have some brand power too!Foot Locker (NYQ:FL) have an NBA partnership now and also the new CEO are looking at expanding and selling in India, with their burgeoning middle class and accompanying middle class income.Nike (NYQ:NKE) 's a bit of a Coca Cola HBC AG (LON:CCH) imo.. mature brand, still great but there are naturally young upstarts hot on their heels!

Abercrombie & Fitch Co (NYQ:ANF) is another apparel retailer the other side of the pond, which has been doing well.It was spun out of the Limited Brands portfolio and had suffered a good few years being out of fashion and marred by a bad brand image.A new CEO turned them around and they're growing at a clip, after the street totally ignored them.I like Victoria's Secret & Co (NYQ:VSCO) too as it was a spin off of the same Limited Brands portfolio fairly recently and i'm hoping the power of the brand can be reinvigorated and turn their still 6 billion, yet currently declining, in revenues into a growing, profitable business.

9
Avatar for donald pond

Totally agree re Abercrombie & Fitch Co (NYQ:ANF) looks to be going great guns and some of the guys I chat to have been buying it recently.

1
Avatar for Zipmanpeter

Great addition to the Stockopedia offer.

42
Avatar for Rambo

Would definitely agree - great recap of the week ahead.

11
Avatar for Indie

Different author, same high quality. 

38
Get the free newsletter